Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Italian Journal of Pediatrics
Published in: Italian Journal of Pediatrics 1/2010

Open Access 01-12-2010 | Case report

Congenital Afibrinogenemia presenting as antenatal intracranial bleed: a case report

Authors: Gopakumar Hariharan, Sivji Ramachandran, Rajiv Parapurath

Published in: Italian Journal of Pediatrics | Issue 1/2010

Login to get access

Abstract

Congenital afibrinogenemia is a very rare inherited coagulation disorder, characterized by virtual absence of plasma fibrinogen (factor I). There are only about 250 cases reported in the world literature [1]. We describe a case of congenital afibrinogenemia which presented as an antenatally detected intracranial bleed.
Appendix
Available only for authorised users
Literature
1.
Leeners JV, Mossakowski J, Kayser S: Case report of congenital afibrinogenemia. Klin Pediatr. 1995, 207: 34-5. 10.1055/s-2008-1046506.CrossRef
2.
Corrigan JJ: 6th edition Blood diseases of infancy and childhood. Edited by: Miller DR, Bachner RL. 1990, St. Louis: C. V. Mosby Company, 866-
3.
Mannucci PM, Duga S, Peyvandi F: Recessively inherited coagulation disorders. Blood. 2004, 104: 1243-10.1182/blood-2004-02-0595.PubMedCrossRef
4.
Scott JP, Montgomery RR: Fibrinogen deficiency (Factor 1). Nelson Textbook of Pediatrics. Edited by: Behrman RE, Kliegman RM, Arvin AM. 2007, Philadelphia: W.B. Saunders Company, 2070-71. 18
5.
Maekawa H, Yamazumi K, Muramatsu S: An A alpha Ser-434 to Nglycosylated Asn substitution in a dysfibrinogen, fibrinogen Caracas II, characterized by impaired fibrin gel formation. J Biol Chem. 1991, 266: 11575-PubMed
6.
Hayes T: Dysfibrinogenemia and thrombosis. Arch Pathol Lab Med. 2002, 126: 1387-PubMed
7.
Hogan KA, Gorkun OV, Lounes KC: Recombinant fibrinogen Vlissingen/Frankfurt IV. The deletion of residues 319 and 320 from the gamma chain of fibrinogen alters calcium binding, fibrin polymerization, cross-linking, and platelet aggregation. J Biol Chem. 2000, 275: 17778-10.1074/jbc.M001618200.PubMedCrossRef
8.
Rosenberg JB, Newman PJ, Mosesson MW, Guillin MC, Amrani DL: Paris I dysfibrinogenemia: A point mutation in intron 8 results in insertion of a 15 amino acid sequence in the fibrinogen gamma-chain. Thromb Haemost. 1993, 69: 217-PubMed
9.
Menache D: Constitutional and familial disorders of fibrinogen. Thromb Haemost. 1964, 13: 172-
10.
Peyvandi F: Rare coagulation disorders. Haemophilia. 2004, 89: 25-
11.
Bolton-Maggs PH, Perry DJ, Chalmers EA: The rare coagulation disorders--Review with guidelines for management from the United Kingdom Haemophilia Centre Doctors' Organisation. Haemophilia. 2004, 10: 593-10.1111/j.1365-2516.2004.00944.x.PubMedCrossRef
12.
Rodriguez RC, Buchanar GR, Clanton MS: Prophylactic cryoprecipitate in congenital afibrinogenemia. Clin Pediatric. 1988, 207: 34-35.
13.
Collet JP, Soria J, Mirshahi M: Dusart syndrome: A new concept of the relationship between fibrin clot architecture and fibrin clot degradability: Hypofibrinolysis related to an abnormal clot structure. Blood. 1993, 82: 2462-PubMed
14.
Lijnen HR, Soria J, Soria C, Collen D, Caen JP: Dysfibrinogenemia (fibrinogen Dusard) associated with impaired fibrin-enhanced plasminogen activation. Thromb Haemost. 1984, 51: 108-PubMed
15.
Wada Y, Lord ST: A correlation between thrombotic disease and a specific fibrinogen abnormality (A alpha 554 Arg>Cys) in two unrelated kindred, Dusart and Chapel Hill III. Blood. 1994, 84: 3709-PubMed
16.
Sauls DL, Lockhart E, Warren ME, Lenkowski A, Wilhelm SE, Hoffman M: Modification of fibrinogen by homocysteine thiolactone increases resistance to fibrinolysis: A potential mechanism of the thrombotic tendency in hyperhomocysteinemia. Biochemistry. 2006, 45: 2480-10.1021/bi052076j.PubMedCrossRef
17.
Galanakis DK: Fibrinogen anomalies and disease. A clinical update. Hematol Clin North Am. 1992, 6: 1171-
Metadata
Title
Congenital Afibrinogenemia presenting as antenatal intracranial bleed: a case report
Authors
Gopakumar Hariharan
Sivji Ramachandran
Rajiv Parapurath
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Italian Journal of Pediatrics / Issue 1/2010
Electronic ISSN: 1824-7288
DOI
https://doi.org/10.1186/1824-7288-36-1

Other articles of this Issue 1/2010

Italian Journal of Pediatrics 1/2010 Go to the issue

Research

Mental health of adolescents who abuse psychoactive substances in Enugu, Nigeria - A cross-sectional study

Research

VNS in drug resistant epilepsy: preliminary report on a small group of patients

Review

Epilepsy and chromosomal abnormalities

Review

The neurobiological basis of ADHD

Research

Relationship between severe obesity and gut inflammation in children: what's next?

Debate

The european paediatric legislation: benefits and perspectives